Clinical Trials Browser

Phase NA × Neoplasm, Residual × Radiotherapy × Clear all

NCT07517705 2026-04-08

MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma

Phase NA Not yet recruiting

Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual